Opioid-Induced Constipation (OIC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Opioid-induced constipation (OIC) is defined as new or worsening of constipation symptoms after initiating, increasing, or modifying opioid therapy and is common in patients on chronic opioid therapy. OIC is primarily mediated through the effects of opioids on μ-receptors in the gastrointestinal tract, reducing bowel tone, contractility, and luminal fecal moisture. · The prevalence of opioid-induced constipation (OIC) was 12.6%. Opioid-induced constipation (OIC) accounts for over 40% to 60% of patients without cancer receiving opioids. Thelansis’s “Opioid-Induced Constipation (OIC) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Opioid-Induced Constipation...